Eris Lifesciences Share Price

Eris Lifesciences Share Price

NSE: ERIS
|
Pharmaceuticals
|
S Cap
₹ 1,313.10
+₹9.60 (0.74%)
1D
Last updated 04 Sep, 2026, 11:29 IST

Eris Lifesciences Share Price Today

As of 4 Sep 2026, Eris Lifesciences share price is ₹1,313.10. The stock opened at ₹1,301.00, compared to its previous close of ₹1,303.50. During today's trading session, Eris Lifesciences share price moved in the range of ₹1,301.00 to ₹1,324.30, with an average price of ₹1,312.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,200.00 and a high of ₹1,799.00. On the performance front, Eris Lifesciences share price has declined by 4.18% over the last six months and is down 26.77% on a year-on-year basis.

₹1,301.00
0.74% up today
₹1,324.30
1D LOW
1D HIGH

Eris Lifesciences Returns Calculator

Circuit
L
H
₹1,042.80
₹1,564.20
52-week
L
H
₹1,200.00
₹1,799.00

About Eris Lifesciences

Eris Lifesciences Share Price
ISIN
INE406M01024
Sector Market Cap
₹ 17,918.8 Cr

Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD), and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women’s health, central nervous system (CNS), oncology, and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.

Eris Lifesciences Financial Highlights

  • Revenue: Eris Lifesciences reported revenue of ₹3,137.17 crore in FY26 vs ₹2,912.00 crore in FY25. It showed an increase of 7.73% on a yearly basis.
  • Operating Profit: Eris Lifesciences reported an operating profit of ₹638.54 crore in FY26 vs ₹488.87 crore in FY25. It showed an increase of 30.62% on a year-on-year basis.
  • Net Profit: Eris Lifesciences reported a net profit of ₹647.51 crore in FY26 vs ₹374.67 crore in FY25. It showed an increase of 72.82% on a yearly basis.

Eris Lifesciences Quarterly Result Highlights

  • Eris Lifesciences reported revenue of ₹875.64 crore in Jun 2026, compared with ₹758.79 crore in Mar 2026, representing an increase of 15.40% on a quarter-on-quarter (QoQ) basis.
  • Eris Lifesciences reported an operating profit of ₹179.49 crore in Jun 2026, compared with ₹159.41 crore in Mar 2026, representing an increase of 12.60% on a quarter-on-quarter (QoQ) basis.
  • Eris Lifesciences reported a profit of ₹143.32 crore in Jun 2026, compared with ₹279.10 crore in Mar 2026, reflecting a decrease of 48.65% on a QoQ basis.
  • The earnings per share (EPS) of Eris Lifesciences stood at ₹25.85 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
54.14%
FII
5.75%
Other DII
1.84%
Retail and other
19.40%
Mutual funds
18.88%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20257.21%
Dec 20256.85%
Mar 20266.39%
Jun 20265.75%
Mkt Cap Cr
17,918.80
P/E
27.14
P/B
4.63
ROE
15.87%
D/E
0.66
ROCE
13.27%
Div. Yield
0.55%
EPS(TTM)
17.86
Turnover
0.28
EV/EBITDA
17.86
Net Margin
0.00%
Op. Margin
0.00%
ROA
9.04%
Quick Ratio
0.00
Curr. Ratio
2.36
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
ERIS Lifescience has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
ERIS Lifescience appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
ERIS Lifescience revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,56,833.0037.705.4713.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,45,426.0083.9114.6415.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,87,320.0086.8922.2825.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,14,833.0024.654.1818.59%0.3117.35%237.300.09%0.3335.38
Cipla1,12,212.0033.443.2611.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,01,155.0092.7719.0916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.594.3523.76%0.0424.88%659.000.84%0.57129.18
Mankind Pharma98,304.7046.845.9411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,405.5030.282.5311.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma95,299.8025.232.479.25%0.1911.76%394.820.25%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Eris Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,893.64₹2,009.15₹1,685.15₹1,347.04
Other Income₹18.36₹23.82₹11.15₹26.09
Total Revenue₹2,912.00₹2,032.97₹1,696.30₹1,373.14
Total Expenses₹2,423.19₹1,601.63₹1,291.66₹930.94
Profit Before Tax₹488.87₹431.34₹404.64₹442.20
Tax₹114.20₹34.22₹30.48₹36.41
Profit After Tax₹374.67₹397.12₹374.16₹405.79
EPS - Basic₹25.85₹28.82₹28.10₹29.89
EPS - Diluted₹25.81₹28.79₹28.07₹29.88

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹638.54₹488.87₹431.34₹404.64
Income before WC changes₹1,120.40₹1,036.92₹685.50₹544.48
Change in Assets-₹414.08₹15.99-₹90.25-₹188.85
Change in Liabilities-₹43.95₹109.98-₹8.49₹13.32
Change in WC-₹458.03₹125.97-₹98.74-₹175.54
Cash flow from Operations₹537.99₹1,065.01₹486.01₹291.74
Cash flow from Investing-₹369.46-₹79.97-₹1,854.52-₹982.10
Cash flow from Financing-₹313.53-₹881.32₹1,379.78₹688.03
Total Cash Flow-₹145.00₹103.72₹11.27-₹2.34
Cash (Start of the year)₹199.74₹94.25₹56.02₹50.87
Cash (End of the year)₹54.74₹199.74₹94.15₹56.02

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹5,810.18₹4,738.42₹2,902.61₹1,644.81
Current Assets₹1,222.99₹2,302.04₹764.72₹627.33
Total Assets₹7,033.17₹7,040.46₹3,667.33₹2,272.14
Current Liabilities₹1,381.39₹2,532.07₹443.23₹199.65
Net Current Asset-₹158.40-₹230.03₹321.49₹427.68
Non-Current Liabilities₹2,380.02₹1,286.30₹1,003.42₹164.29
Equity Capital₹3,271.76₹3,222.09₹2,220.68₹1,908.20
Total Equity & Liabilities₹7,033.17₹7,040.46₹3,667.33₹2,272.14

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,697.75₹1,486.71₹1,330.73₹1,215.73
Other Income₹35.51₹34.83₹17.26₹28.99
Total Revenue₹1,733.26₹1,521.54₹1,347.99₹1,244.72
Total Expenses₹1,613.21₹1,192.70₹911.08₹786.18
Profit Before Tax₹120.05₹328.84₹436.91₹458.54
Tax₹42.66₹29.12₹38.90₹41.35
Profit After Tax₹77.39₹299.72₹398.01₹417.19
EPS - Basic₹5.69₹22.04₹29.27₹30.70
EPS - Diluted₹5.68₹22.01₹29.23₹30.70

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹362.05₹120.05₹328.83₹436.91
Income before WC changes₹625.22₹513.61₹472.95₹510.61
Change in Assets₹38.19₹117.87-₹102.33-₹122.00
Change in Liabilities-₹24.54₹83.82₹39.15₹11.50
Change in WC₹13.65₹201.69-₹63.18-₹110.50
Cash flow from Operations₹563.94₹701.87₹336.29₹322.33
Cash flow from Investing-₹694.16-₹358.99-₹2,491.89-₹513.30
Cash flow from Financing₹71.06-₹310.47₹2,160.05₹193.75
Total Cash Flow-₹59.16₹32.41₹4.45₹2.78
Cash (Start of the year)₹84.34₹51.93₹47.48₹44.70
Cash (End of the year)₹25.18₹84.34₹51.93₹47.48

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹4,594.89₹3,473.03₹2,231.58₹1,570.41
Current Assets₹627.54₹1,876.54₹552.08₹580.01
Total Assets₹5,222.43₹5,349.57₹2,783.66₹2,150.42
Current Liabilities₹993.94₹2,261.79₹283.77₹166.24
Net Current Asset-₹366.40-₹385.25₹268.30₹413.77
Non-Current Liabilities₹1,713.59₹563.76₹278.00₹65.62
Equity Capital₹2,514.90₹2,524.02₹2,221.88₹1,918.56
Total Equity & Liabilities₹5,222.43₹5,349.57₹2,783.66₹2,150.42
* All values are in INR Crore
Qty
Bid
5
1312.9
9
1312.8
1
1312.7
8
1312.6
3
1312.5
Ask
Qty
1313.6
5
1313.9
4
1314
4
1314.1
7
1314.3
15
Bid Total: 26
Ask Total: 35
Buy orders: 43%
Sell orders: 57%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
36.99
Neutral
ATR (14)
32.39
Neutral
STOCH(9,6)
45.28
Neutral
STOCH RSI (14)
62.15
Neutral
ADX(9)
40.32
Bearish
UO(9)
36.45
Neutral
ROC(12)
-3.45
Bearish
WillR(14)
-63.39
Neutral
Period
Simple value
Exponential vaue
5D
1300.86
1301.79
10D
1309.06
1311.27
20D
1336.03
1331.52
50D
1388.96
1364.43
100D
1386.09
1382.45
Volume trend — traded volume by day
4 Sep0L
3 Sep0L
2 Sep1L
1 Sep0L
31 Aug0L
28 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Eris Lifesciences Share Price
Eris Lifesciences
Pharmaceuticals
Add Stock
Add Another

Eris Lifesciences Share Price FAQs

Eris Lifesciences share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837